Skip to content

Drug interactions

Nalbuphine + Tranylcypromine

Severity: Major

Nalbuphine and Tranylcypromine: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Combining an MAO inhibitor with an opioid analgesic can cause unpredictable reactions, including profound hypotension, hyperthermia, marked sedation, respiratory depression and occasionally death. Nalbuphine has weak serotonergic activity, so excitatory serotonin-toxicity-type reactions are less likely than with other opioids but cannot be excluded.

What this interaction means in plain words

Nalbuphine and Tranylcypromine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Nalbuphine belongs to Musculoskeletal; Tranylcypromine belongs to Central Nervous System.

Evidence level: Low

Why it happens

Irreversible MAO inhibition may potentiate opioid CNS and cardiovascular depression and may contribute to serotonergic toxicity; the exact mechanism is not fully established.

What to do

Avoid nalbuphine during and for 14 days after stopping tranylcypromine; choose a non-opioid or alternative analgesic. If unavoidable, use a reduced starting dose with careful titration and monitor blood pressure, temperature, mental status and respiration.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nalbuphine and Tranylcypromine, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nalbuphine with Tranylcypromine?

MediHelp rates the interaction as major. Nalbuphine and Tranylcypromine can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Combining an MAO inhibitor with an opioid analgesic can cause unpredictable reactions, including profound hypotension, hyperthermia, marked sedation, respiratory depression and occasionally death. Nalbuphine has weak serotonergic activity, so excitatory serotonin-toxicity-type reactions are less likely than with other opioids but cannot be excluded.

How serious is the interaction between Nalbuphine and Tranylcypromine?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid nalbuphine during and for 14 days after stopping tranylcypromine; choose a non-opioid or alternative analgesic. If unavoidable, use a reduced starting dose with careful titration and monitor blood pressure, temperature, mental status and respiration.

What other medicines interact with Nalbuphine?

MediHelp also lists interactions of Nalbuphine with, for example, Alvimopan, Olanzapine / samidorphan, Alprazolam. The full list is on the Nalbuphine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in